Zyxin expression levels in non-small cell lung cancer patients
Background/Aim. Non-small cell lung cancer (NSCLC) is the most common cause of cancer-related mortality worldwide. Early detection represents one of the most promising approaches to reduce lung cancer mortality. Zyxin (ZYX) is a member of the focal adhesion protein family, recently identified as a p...
Main Authors: | Ilić Dejan, Rančić Milan, Stoimenov-Jevtović Tatjana, Petrović Veljko, Petrović Marina |
---|---|
Format: | Article |
Language: | English |
Published: |
Military Health Department, Ministry of Defance, Serbia
2020-01-01
|
Series: | Vojnosanitetski Pregled |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2020/0042-84501900017I.pdf |
Similar Items
-
Expression of Zyxin in Non-Small Cell Lung Cancer—A Preliminary Study
by: Aleksandra Partynska, et al.
Published: (2022-06-01) -
Zyxin is involved in fibroblast rigidity sensing and durotaxis
by: Yip, Ai Kia, et al.
Published: (2022) -
Zyxin Is Involved in Fibroblast Rigidity Sensing and Durotaxis
by: Ai Kia Yip, et al.
Published: (2021-11-01) -
Zyxin inhibits the epithelial–mesenchymal transition process in gastric cancer by upregulating SIRT1
by: Jing Lou, et al.
Published: (2023-10-01) -
The role of zyxin in signal transduction and its relationship with diseases
by: Zelan Wu, et al.
Published: (2024-04-01)